Zhang Jie - Xiangyu Medical Head Center
| 688626 Stock | 31.72 0.23 0.73% |
Executive
Zhang Jie is Head Center of Xiangyu Medical Co
| Age | 39 |
| Address | Middle Section of Diku Avenue, Anyang, China, 456300 |
| Phone | 86 37 2777 6088 |
| Web | https://www.xyyl.com |
Xiangyu Medical Management Efficiency
The company has return on total asset (ROA) of 0.0209 % which means that it generated a profit of $0.0209 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0593 %, meaning that it generated $0.0593 on every $100 dollars invested by stockholders. Xiangyu Medical's management efficiency ratios could be used to measure how well Xiangyu Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Xiangyu Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 283.5 M, whereas Total Assets are forecasted to decline to about 1.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rongchun Cheng | Jiangsu Yueda Investment | 53 | |
| Dagang Qin | Jiangsu Yueda Investment | 41 | |
| Jiansong Zhang | Jiangsu Yueda Investment | 56 | |
| Bin Liu | Jiangsu Yueda Investment | 50 | |
| Liu Zhou | Shenzhen Centralcon Investment | 59 | |
| Weifang Yang | Zhejiang Kingland Pipeline | 53 | |
| Zhao Shanhu | Jiangsu Yueda Investment | 41 | |
| Feng Chi | Tieling Newcity Investment | 47 | |
| Chao Cai | Zhejiang Kingland Pipeline | 40 | |
| Xiuhua Ma | Jiangsu Yueda Investment | 55 | |
| Tiecheng Zhang | Tieling Newcity Investment | 52 | |
| Bin CPA | Jiangsu Yueda Investment | 50 | |
| Zhongsen Liu | Hainan Mining Co | 42 | |
| Yanyong Kang | Western Mining Co | 54 | |
| Tong Zhu | Hainan Mining Co | 43 | |
Management Performance
| Return On Equity | 0.0593 | ||||
| Return On Asset | 0.0209 |
Xiangyu Medical Leadership Team
Elected by the shareholders, the Xiangyu Medical's board of directors comprises two types of representatives: Xiangyu Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xiangyu. The board's role is to monitor Xiangyu Medical's management team and ensure that shareholders' interests are well served. Xiangyu Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xiangyu Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhiqiang Li, Director Center | ||
| Hongfeng Jin, Financial Director | ||
| Jing Liu, Board Sec | ||
| Zhang Jie, Head Center | ||
| Zuoqin Wei, Deputy Mang | ||
| Junling Guo, Deputy Director | ||
| Yongzheng He, GM Chairman | ||
| Jin Li, Chief Officer |
Xiangyu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xiangyu Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0593 | ||||
| Return On Asset | 0.0209 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 4.68 B | ||||
| Shares Outstanding | 160 M | ||||
| Shares Owned By Insiders | 74.80 % | ||||
| Shares Owned By Institutions | 4.09 % | ||||
| Price To Book | 2.51 X | ||||
| Price To Sales | 7.23 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Xiangyu Stock
Xiangyu Medical financial ratios help investors to determine whether Xiangyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiangyu with respect to the benefits of owning Xiangyu Medical security.